ADVB: Advanced Biomed Operatsion marja

Advanced Biomed Inc. (ADVB) brendining ramzi va logotipi

Advanced Biomed Inc (ADVB) metastazlarni juda erta aniqlash uchun mo‘ljallangan noyob mikrochiplari tufayli sezilarli narx belgilash imkoniyatiga ega. GURU.Markets servisida operatsion marjaning chiziqli grafigi taqdim etilgan bo‘lib, u yerda -5855.30 ushbu ko‘rsatkichning joriy qiymatini belgilaydi. Biroq, uzoq muddatli shartnomalar orqali komponentlar yetkazib berilishining barqarorligi va profilaktik qon skriningiga qaratilgan strategik e'tibor foydada yashirin anomaliyalar mavjudligini kritik baholashni talab qiladi.

ADVB: Advanced Biomed Inc. Sotuvning operatsion rentabelligi 07.03.2025 - 19.11.2026

Advanced Biomed Inc. - tahliliy kesimlar va asosiy koʻrsatkichlar (ADVB)

Kompaniyaning jamlanma tahlili:Advanced Biomed Corp, ADVB
Advanced Biomed brendining mahsuloti

Mikrofluidikaning saraton skriningiga integratsiyasi Advanced Biomed Inc (ADVB) kompaniyasiga yuqori texnologiyali erta diagnostika testlarini monetizatsiya qilish imkonini beradi. Operatsion foyda marjasini tahlil qilish orqali investor qarz majburiyatlari va soliqlarni hisobga olguncha asosiy biznesning samaradorligini baholaydi, bu esa kompaniyaning xarajatlarni iste'molchilarga yuklash qobiliyatini namoyish etadi va hisobot vaqtining kechikishlarisiz real kapital zaxirasini tasdiqlaydi.

Raqobatchilar tahlili

Operatsion rentabellik BeiGene Ltd|Halozyme Therapeutics - Operatsion foyda marjasi|Sotuvning operatsion marjasi RVMD (Revolution Medicines Corp)|Operatsion foyda koeffitsiyenti AAPG|Operatsion rentabellik CG Oncology Therapeutics CGON|Operatsion foyda normasi URGN|BCAX: Sotuvning operatsion marjasi|PSNL: Operatsion rentabellik|Erasca (ERAS) - Operatsion rentabellik|DCTH - Operatsion faoliyat rentabelligi|YMAB (Y-mAbs Corp) - Operatsion marja|Sotuvning operatsion marjasi Aura Biosciences (AURA)|Operatsion rentabellik Candel Therapeutics Inc. (CADL)|Sotuvning operatsion marjasi Accuray, Inc. ARAY|Operatsion rentabellik sellaslifesciences.com SLS|Operatsion foyda normasi ACTU|CTOR - Operatsion rentabellik|Operatsion faoliyat rentabelligi tuhurabio.com HURA|Protara Therapeutics, Inc. (TARA) - Operatsion rentabellik|FATE: Operatsion foyda koeffitsiyenti|WHWK (Aadi Bioscience, Inc.) - Operatsion marja|TCRX (TScan Therapeutics) - Operatsion foyda koeffitsiyenti|Operatsion rentabellik Champions Oncology (CSBR)|Operatsion faoliyat rentabelligi XBiotech USA|Operatsion rentabellik CEL-SCI CVM|OS Therapies, Inc. (OSTX) - Sotuvning operatsion rentabelligi|RADX - Operatsion rentabellik|ARTV - Operatsion marja|Adlai Nortye Ltd (ANL) - Operatsion rentabellik|Veru Pharma - Operatsion foyda normasi|Operatsion rentabellik Tempest Therapeutics Corp|Operatsion foyda bo'yicha sotuv rentabelligi XLO (Xilio Therapeutics, Inc.)|Operatsion marja RENB|MURA (Mural Oncology) - Operatsion foyda normasi|Operatsion marja KAPA (Kairos Pharma Ltd)|OKUR: Operatsion foyda bo'yicha sotuv rentabelligi|GDTC: Sotuvning operatsion marjasi|CRIS - Operatsion marja|APLM: Operatsion marja|Sotuvning operatsion rentabelligi tharimmune.com (THAR)|Sotuvning operatsion marjasi GNPX|Operatsion foyda bo'yicha sotuv rentabelligi CLDI (Calidi Biotherapeutics)|Operatsion marja SBFM|Xenetic Biosciences, Inc. - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion rentabellik Salarius Pharmaceuticals SLRX|Operatsion marja purple-biotech.com PPBT|AONC - Operatsion rentabellik|BGNE: Operatsion rentabellik|CKPT: Operatsion marja|Elevation Oncology - Operatsion foyda normasi|ICAD (iCAD) - Operatsion marja|IKNA: Operatsion foyda normasi|Operatsion rentabellik Notable Labs (NTBL)|VIRX (Viracta Therapeutics, Inc.) - Operatsion foyda normasi|Operatsion rentabellik MorphoSys Corporation MOR|NAYA: Operatsion foyda bo'yicha sotuv rentabelligi|Ascentage Pharma Group International - Operatsion marja